DE60322969D1 - Neue pharmakologisch aktive dauerpheromonverbindung zur steuerung von alterung und stress sowie verfahren zu deren isolierung und kennzeichnung - Google Patents

Neue pharmakologisch aktive dauerpheromonverbindung zur steuerung von alterung und stress sowie verfahren zu deren isolierung und kennzeichnung

Info

Publication number
DE60322969D1
DE60322969D1 DE60322969T DE60322969T DE60322969D1 DE 60322969 D1 DE60322969 D1 DE 60322969D1 DE 60322969 T DE60322969 T DE 60322969T DE 60322969 T DE60322969 T DE 60322969T DE 60322969 D1 DE60322969 D1 DE 60322969D1
Authority
DE
Germany
Prior art keywords
stress
extract
ethanol
insulation
identification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60322969T
Other languages
English (en)
Inventor
Young Ki Paik
Pan Young Jeong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KDR Biotech Co Ltd
Original Assignee
KDR Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KDR Biotech Co Ltd filed Critical KDR Biotech Co Ltd
Application granted granted Critical
Publication of DE60322969D1 publication Critical patent/DE60322969D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
DE60322969T 2002-11-14 2003-10-07 Neue pharmakologisch aktive dauerpheromonverbindung zur steuerung von alterung und stress sowie verfahren zu deren isolierung und kennzeichnung Expired - Lifetime DE60322969D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020020070591A KR100700884B1 (ko) 2002-11-14 2002-11-14 약학적으로 유용한 노화 및 스트레스 조절용 신규 페로몬 화합물 및 그 분리정제방법
PCT/KR2003/002059 WO2004043944A1 (en) 2002-11-14 2003-10-07 Pharmacologically active novel dauer pheromone compound for controlling aging and stress and method for isolating and characterizing the same

Publications (1)

Publication Number Publication Date
DE60322969D1 true DE60322969D1 (de) 2008-09-25

Family

ID=36147023

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60322969T Expired - Lifetime DE60322969D1 (de) 2002-11-14 2003-10-07 Neue pharmakologisch aktive dauerpheromonverbindung zur steuerung von alterung und stress sowie verfahren zu deren isolierung und kennzeichnung

Country Status (13)

Country Link
US (1) US7119213B2 (de)
EP (1) EP1603894B1 (de)
JP (1) JP2006506420A (de)
KR (1) KR100700884B1 (de)
CN (1) CN1323078C (de)
AT (1) ATE404549T1 (de)
AU (1) AU2003265002A1 (de)
BR (1) BR0315265A (de)
CA (1) CA2462181A1 (de)
DE (1) DE60322969D1 (de)
MX (1) MXPA05005103A (de)
RU (1) RU2303596C2 (de)
WO (1) WO2004043944A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100556335B1 (ko) * 2004-02-05 2006-03-03 정만길 6알-(3,6-디데옥시-엘-아라비노-헥소피라노실옥시)헵타노익산, 그 제조방법 및 그를 포함하는 장기휴면 유발효과
BR112014003008A2 (pt) * 2011-08-08 2017-02-21 Boyce Thompson Intitute For Plant Res "compostos e métodos de modificação de comportamento de um nemátodo”
BR112014003007A2 (pt) 2011-08-08 2017-03-01 Boyce Thompson Intitute For Plant Res compostos de mólecula pequena que controlam nemátodos patogênicos de inseto e planta
KR101384330B1 (ko) * 2012-01-17 2014-04-14 연세대학교 산학협력단 다우몬을 유효성분으로 함유하는 항염증용 약학적 조성물
CN109843309A (zh) 2016-08-25 2019-06-04 加利福尼亚技术学院 自身免疫性和炎性疾病的蛔甙治疗
CN114423774A (zh) 2019-05-17 2022-04-29 加利福尼亚技术学院 蛔苷衍生物和使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3227030B2 (ja) * 1993-06-10 2001-11-12 日東電工株式会社 生理活性δ−ラクトンの合成方法
US6077867A (en) 1998-01-21 2000-06-20 Fideline Pig appeasing pheromones to decrease stress, anxiety and aggressiveness

Also Published As

Publication number Publication date
WO2004043944A1 (en) 2004-05-27
CN1692107A (zh) 2005-11-02
US7119213B2 (en) 2006-10-10
EP1603894A4 (de) 2006-09-27
EP1603894B1 (de) 2008-08-13
JP2006506420A (ja) 2006-02-23
EP1603894A1 (de) 2005-12-14
BR0315265A (pt) 2005-08-23
ATE404549T1 (de) 2008-08-15
KR100700884B1 (ko) 2007-03-29
RU2005118102A (ru) 2006-01-20
CN1323078C (zh) 2007-06-27
US20050075389A1 (en) 2005-04-07
RU2303596C2 (ru) 2007-07-27
AU2003265002A1 (en) 2004-06-03
KR20040042338A (ko) 2004-05-20
MXPA05005103A (es) 2005-09-30
CA2462181A1 (en) 2004-05-14

Similar Documents

Publication Publication Date Title
Steyn The structures of five diketopiperazines from Aspergillus ustus
DK1809663T3 (da) Fremgangsmåde til oprensning af FSH
IS6607A (is) Aðferð við framleiðslu peptíða með notkun umritunar-/þýðingarkerfa í tilraunaglasi
RU2009122202A (ru) Чистая форма рапамицина и способ ее выделения и очистки
RU2008128485A (ru) Флавоноидное соединение, обладающее противовирусной активностью
NZ587511A (en) Purified lymphotoxin-beta-receptor immunoglobulin fusion proteins and methods of their purification
ATE416152T1 (de) Verfahren zur abtrennung von modafinil
DE60322969D1 (de) Neue pharmakologisch aktive dauerpheromonverbindung zur steuerung von alterung und stress sowie verfahren zu deren isolierung und kennzeichnung
CA2548297A1 (en) Process for the purification of macrolides
KR101590255B1 (ko) 미생물 Bacillus vallismortis BS07M 균주 발효액으로부터 제조된 고리형 다이펩타이드의 제조방법
Fujioka et al. Isolation and identification of nicotinic acid as a flower-inducing factor in Lemna
JP3236282B1 (ja) プラバスタチンを精製する方法
Aberhart et al. Separation by high-performance liquid chromatography of (3R)-and (3S)-β-leucine as diastereomeric derivatives
Shinde et al. Identification of a new impurity in lisinopril
Della Sala et al. Towards the biosynthesis of the aromatic products of the Mediterranean mollusc Scaphander lignarius: Isolation and synthesis of analogues of lignarenones
EP3474847B1 (de) Verfahren zur herstellung von eluxadolin
ATE395360T1 (de) Neues verfahren zur aufreinigung von humanem wachstumshormon
KR100870784B1 (ko) 효모로부터 유래한 콜레스테롤에스터라제에 의한엔안티오퓨어 중간체의 효소적 합성
Wright et al. Synthesis and spectroscopic characterization of enantiopure protected trans-4-amino-1-oxyl-2, 2, 6, 6-tetramethyl piperidine-3-carboxylic acid (trans β-TOAC)
JP2015139433A (ja) ポリアミンコンジュゲートの製造方法
JP2792010B2 (ja) フタリド誘導体及びこれを有効成分とする子宮頚癌細胞の殺細胞剤
S'kof et al. Stereoselective Amination of 5‐Substituted γ‐Lactones and γ‐Lactams–A Convenient Route for the Preparation of 5‐Substituted (3S, 5S)‐3‐Acetylaminotetrahydrofuran‐2‐ones and (3S, 5S)‐3‐Acetylaminopyrrolidin‐2‐ones
Ragasa et al. Triterpenes and Sterol from Tabernaemontana pandacaqui poir.
White et al. STUDIES ON ADRENOCORTICOTROPIN. XIII. THE ISOLATION OF TWO HIGHLY ACTIVE BOVINE TYPES
Tani et al. A plant growth retardant related to chlamydocin and its proposed mechanism of action

Legal Events

Date Code Title Description
8364 No opposition during term of opposition